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At a conceptual level, food antigen exposure to damaged skin can result in an immune response 
producing food allergy.1–4 Food antigen exposure to HEALTHY skin can produce a tolerogenic 
response, protecting against food allergy.5 Animal antigen exposure to damaged skin can result in an 
immune response producing autoimmunity due to molecular mimicry (protein sequence homology) 
between human and animal proteins.6,7 Therefore animal antigen exposure to HEALTHY skin can be a 
route to produce a tolerogenic response protecting against autoimmunity.
Mechanism of action
Peanut protein patch applied to HEALTHY skin is a treatment for peanut allergy.8,9 One of the ways 
such epicutaneous immunotherapy (EPIT) works, is the generation of antigen-specific regulatory T 
cells (Tregs).10Tregs regulate/moderate the immune system's reaction to peanut exposure.
One of the causes of type 1 diabetes (T1D) is a reduction in the number and or alteration of Treg 
function in the pancreas. This allows autoreactive CD8+ T cells to destroy the islet cells with little 
inhibition, resulting in T1D.11,12
Why chicken protein?
As described previously6,7, chicken proteins in chick embryo cell culture contaminated vaccines are the 
most likely source of antigens for the activation of autoreactive CD8+ T cells in T1D. Therefore 
expansion of chicken antigen-specific Tregs will be most effective in inhibiting the activity of these 
autoreactive T cells.
An effective immune response against an antigen requires suppression of Treg function associated with 
that antigen. So chicken protein contaminated vaccines that immunize against chicken antigens can be 
expected to suppress the function of antigen-specific Tregs associated with chicken epitopes and cross-
reacting self epitopes. 
 
Why topical and not ingested chicken protein?
Tregs are trained to migrate to certain parts of the body.10 Ingested chicken proteins generate Tregs that 
home to the gut. Topical chicken protein generates Tregs that home to the skin.
As described previously6,7, the CD8+ T cells that destroy islet cells, express skin homing receptors. 
This is evidence that the pancreatic tissue also secrete ligands that are chemoattractants for skin homing
receptors. Therefore skin homing Tregs produced by topical chicken protein will also migrate to the 
pancreas just like the autoreactive CD8+ T cells. Once they migrate to the pancreas, they are able to 
suppress autoreactive T cells.
Source of chicken protein
The source could be as simple as chicken broth applied to healthy skin. Commercial products could be 
similar to the Viaskin peanut patch for peanut allergy. Commercial products can of course choose to 
restrict the chicken proteins to known T1D autoantigens such as GAD65, IA-2, etc. and include T1D 
autoantigens from other animal proteins that contaminate vaccines (guinea pig, pig, bovine, African 
green monkey, Madin Darby Canine, etc. proteins)13.
Cancer and autoimmunity prevention
The immune system navigates a fine line between cancer protection and autoimmunity. The type of 
immune response is especially important for animal protein derived peptides that mimic self peptides. 
Upregulated Treg function will result in a weak response against cancer. Suppression of Treg function 
will increase risk of autoimmunity.
So if this treatment works, a caveat is that Treg levels should not go too high as to risk lower protection
against cancer. 
This further emphasizes the need to clean up our vaccines by removing ALL non-target proteins. Once 
mis-programmed, it is extremely difficult to reprogram the immune system and maintain this fine 
natural balance. Vaccines have been good at “prevention is better than cure” for infectious diseases. 
Prevention is obviously better than cure for non-communicable diseases as well. 
For decades, vaccinologists have been reluctant to understand the immunological mechanism of how 
vaccines work or hurt the body. Pulendran et al.14 write: 
“Despite their success, one of the great iro-nies of vaccinology is that the vast majority of vaccines 
have been developed empirically, with little or no understanding of the immunological mechanisms by 
which they induce protective immunity. However, the failure to develop vaccines against global 
pandemics such as infection with human immunodeficiency virus (HIV) despite decades of effort has 
underscored the need to understand the immunological mechanisms by which vaccines confer 
protective immunity.”
 
Like the vaccinologists, pharmaceutical companies also fail to understand the immunological 
mechanisms of other products. Monoclonal antibody products produced on Chinese Hamster Ovary 
(CHO) cells began to fail due to the induction of anti-drug antibodies (ADA) against the animal 
peptides. The pharmaceutical companies and regulators have ignored immune responses to injected 
animal proteins for decades. Now with ADA, they have been forced to look at the issue15.
Dr. Vibha Jawa, a director with Merck commented on the article below (see comments section):
“We are beginning to look at residual proteins and contaminant with vaccines
Depending on animal protein a degree of homology with human self can be evaluated using algorithm 
to understand the extent of tolerance.
Additionally in vitro human immune cell assays can be run to understand thersholds of these proteins 
and their adjuvant effects”
https://www.researchgate.net/publication/305628626_Evaluating_Immunogenicity_Risk_Due_to_Host
_Cell_Protein_Impurities_in_Antibody-Based_Biotherapeutics
So, immunotoxic effects of non-target proteins in general and animal proteins in particular, that 
contaminate vaccines, have not been studied or understood thus far. Such poorly designed, poorly 
understood vaccines have been administered for decades and continue to be administered. 
Unfortunately, these immunotoxic vaccines have therefore caused the epidemic of allergy2–4, asthma3, 
autism16,17, autoimmune diseases6,7,18–27 and require a complete re-design28.
Conclusion 
Going by the peanut patch experience, it could take up to a year to see the effect of the treatment, if this
mechanism works.
While the specific case of chicken protein and T1D were described, obviously the concept applies 
widely to all animal proteins contaminating vaccines13 and the various corresponding autoimmune 
diseases they induce.
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